Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user sitting outside with his wife and daughter.
Potential OPDIVO® (nivolumab) user sitting outside with his wife and daughter.

Clinical trial results for
non-small cell lung
cancer (NSCLC)

See results for OPDIVO immunotherapy, alone or in combination with other therapies

Actor portrayals.

Advanced NSCLC

OPDIVO + YERVOY

For certain adults with previously untreated advanced NSCLC that tests positive for PD-L1

Advanced NSCLC

OPDIVO + YERVOY with limited chemotherapy

For adults with previously untreated advanced NSCLC

Early-stage NSCLC before and after surgery

OPDIVO with chemotherapy followed by OPDIVO alone

For adults with early-stage NSCLC, before and after surgery

Early-stage NSCLC before surgery

OPDIVO with chemotherapy

For adults with early-stage NSCLC before surgery

Previously treated advanced NSCLC

OPDIVO

For adults who have had prior treatments for NSCLC

OPDIVO and OPDIVO-based combination treatments will not work for everyone. Individual results may vary.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

How treatment works

See how this treatment may help your body fight cancer

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

Nurse monitoring a gentleman's infusion of OPDIVO® (nivolumab) immunotherapy treatment.

Getting an infusion

See your recommended treatment plan and what to expect from an infusion



1506-US-2400468 09/24